Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 2,755,725 | 2,334,736 | 2,288,363 | 2,412,409 | 1,993,843 |
| Cost of Goods | 1,914,347 | 1,642,650 | 1,645,499 | 1,726,306 | 1,455,601 |
| Gross Profit | 841,378 | 692,086 | 642,864 | 686,103 | 538,242 |
| Operating Expenses | 679,100 | 578,556 | 570,281 | 598,995 | 529,398 |
| Operating Income | 162,625 | 114,180 | 73,082 | 87,414 | 9,445 |
| Interest Expense | 17,911 | 15,610 | 15,609 | 20,292 | 18,701 |
| Other Income | 7,687 | 3,098 | 2,050 | 2,328 | 4,730 |
| Pre-tax Income | 152,401 | 101,668 | 59,523 | 69,450 | -4,526 |
| Income Tax | 53,010 | 37,142 | 21,623 | 27,117 | -120 |
| Net Income Continuous | 99,391 | 64,526 | 37,900 | 42,333 | -4,406 |
| Net Income Discontinuous | N/A | N/A | N/A | -49,098 | N/A |
| Net Income | $99,391 | $64,526 | $38,042 | $-6,086 | $-4,406 |
| EBITDA(a) | $162,625 | $114,180 | $73,082 | $87,414 | $9,445 |